Theravance Biopharma to Host Key Opinion Leader Event Focused on the Unmet Medical Need in the Treatment of Neurogenic Orthostatic Hypotension

Live Event and Webcast from 12:00 – 1.30 p.m. ET on Thursday, May 24th DUBLIN , May 17, 2018 /PRNewswire/ —   Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that it will host a key opinion leader event focusing on neurogenic orthostatic hypotension (nOH) beginning at 12:00 p.m.


Leave a Reply

Your email address will not be published.